Johnson v. Maurer

CourtDistrict Court, D. Connecticut
DecidedApril 29, 2021
Docket3:18-cv-00694
StatusUnknown

This text of Johnson v. Maurer (Johnson v. Maurer) is published on Counsel Stack Legal Research, covering District Court, D. Connecticut primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Johnson v. Maurer, (D. Conn. 2021).

Opinion

UNITED STATES DISTRICT COURT DISTRICT OF CONNECTICUT

CARVAUGHN JOHNSON,

Plaintiff, Civil Action No. 3:18-cv-694 (CSH) v.

SYED JOHAR NAQVI and APRIL 29, 2021 CAPTAIN OGANDO,

Defendants.

RULING ON DEFENDANTS’ MOTION FOR SUMMARY JUDGMENT

HAIGHT, Senior District Judge: Plaintiff Carvaughn Johnson (“Plaintiff”) currently is incarcerated at MacDougall-Walker Correctional Institution (“MWCI”) and filed a pro se Complaint pursuant to 42 U.S.C. § 1983 against twelve of the facility’s employees. Doc. 1 (“Compl.”). Plaintiff thereafter filed an Amended Complaint. Doc. 6 (“Am. Compl.”). The Court then filed an Initial Review Order, in which it permitted four claims to proceed against two individuals in their personal capacities: (1) a claim of First Amendment retaliation against Captain Ogando (“Ogando”) for a strip search that Ogando allegedly ordered without a penological purpose; (2) a Fourth Amendment violation against Ogando for the same strip search; (3) a claim of deliberate indifference to serious medical needs, in violation of the Eighth Amendment, against Dr. Syed Johar Naqvi (“Dr. Naqvi,” and collectively with Ogando, “Defendants”) regarding his failure to treat Plaintiff’s injuries stemming from a falling cabinet door; and (4) a claim of recklessness under state law against Dr. Naqvi based on his failure to treat Plaintiff. See Johnson v. Maurer, No. 18 Civ. 694 (CSH), 2018 WL 6421059 (D. Conn. Dec. 6, 2018). Defendants filed a motion for summary judgment, seeking to dismiss all of Plaintiff’s claims. Doc. 21 (“Mot.”); Doc. 21-1 (“Defs.’ Mem.”). Plaintiff opposes Defendants’ motion

in all respects. Doc. 26, at 12–15 (“Pl.’s Mem.”). This Ruling resolves Defendants’ motion. I. BACKGROUND The following facts are derived from the Parties’ submissions. Doc. 21-7 (“Defs.’ 56(a)”); Doc. 26, at 1–11 (“Pl.’s 56(a)”). Unless otherwise noted, they are undisputed. A. Medical Treatment On May 21, 2017, Plaintiff saw Dr. Naqvi, complaining of foot pain. Defs.’ 56(a) ¶ 1. Dr. Naqvi prescribed Plaintiff Motrin, otherwise known as ibuprofen, a nonsteroidal anti-inflammatory drug (NSAID) that relieves pain and reduces inflammation. Id. ¶ 2.1 Dr. Naqvi wrote the Motrin prescription for three months—from May 21, 2017 until August 21, 2017—and instructed Plaintiff to take one eight-hundred milligram pill of Motrin twice a day.

Id. ¶ 4. The Motrin prescription was a “keep on person” (“KOP”) prescription, meaning that Plaintiff would be provided with a certain number of pills in a bottle to keep with him in his cell to take at regular intervals. Id. ¶ 5. According to Defendants, Plaintiff received regular supplies of Motrin on May 23, May 27, June 3, June 10, June 17, June 24, June 27, July 1, July 7, July 15, July 22, July 29, August 5, and August 12, 2017. Id. ¶ 6.2

1 NSAIDs do not target a specific part of the body, but rather relieve pain to all portions of the body, meaning that if a patient took Motrin for a pain in one part of his body, it would still relieve pain to other parts of the body as well. Defs.’ 56(a) ¶ 3. 2 According to Plaintiff, Defendants’ description of KOP prescriptions is misleading because medication distribution has recently changed to once every month. Pl.’s 56(a), at 4 ¶ 6. It is unclear, however, how this impacts Plaintiff’s underlying access to medication. Dr. Naqvi next saw Plaintiff on June 25, 2017, for complaints of shoulder pain and foot fungus. Id. ¶ 7. Dr. Naqvi did not order any additional pain medication for Plaintiff because he already was receiving Motrin regularly from the previous prescription. Id. ¶ 8. However, Dr. Naqvi did prescribe Plaintiff antifungal medication for his foot. Id. ¶ 9.

Dr. Naqvi then saw Plaintiff on July 24, 2017 and treated Plaintiff’s foot fungus and his complaints of shoulder and neck pain. Id. ¶ 10. Plaintiff’s fungus had cleared up, but he reported that he had reduced range of motion in his neck. Id. ¶ 11. Dr. Naqvi therefore ordered c-spine x-rays, which were completed on July 25, 2017. Id. ¶ 12. The x-rays revealed no injuries to Plaintiff. Id. ¶ 13. Plaintiff received a new Motrin prescription from a nurse practitioner on August 14, 2017. Id. ¶ 14. This prescription was for an additional three months—to expire in November 2017—and again Plaintiff was to take an eight-hundred milligram tablet of Motrin twice a day. Id. ¶ 15. The prescription also was KOP. Id. ¶ 16.3 Plaintiff received supplies of Motrin on August 17, August 26, September 2, September 9, September 16, September 23, September 30,

October 7, October 14, October 21, October 28, November 4, and daily from November 11 to November 30, 2017. Id. ¶ 17. Dr. Naqvi next saw Plaintiff on August 27, 2017 and treated his complaints of neck and chest pain. Id. ¶ 18. Dr. Naqvi explained to Plaintiff that his previous x-rays were normal and revealed no injuries. Id. ¶ 19. According to Plaintiff, at the August 27 appointment, Plaintiff

3 Plaintiff objects to a number of the facts in Defendants’ Rule 56(a) submission, arguing, for example, that the citations to which Defendants refer “ha[ve] nothing to [do] with the facts defendants are asserting.” Pl.’s 56(a), at 4 ¶¶ 14–16. The Court construes Plaintiff’s argument as a reference to Local Rule 56, which requires that “[e]ach material fact set forth in the Local Rule 56(a)1 Statement” must be “supported by the evidence.” D. Conn. Local R. 56. However, contrary to Plaintiff’s assertion, Defendants have made proper citations. For example, Defendants claim that “Plaintiff received a new Motrin prescription from a nurse practitioner on August 14, 2017.” Defs.’ 56(a) ¶ 14. Defendants then cite to page 212 of Exhibit A to their motion (Plaintiff’s medical records), which indicates that Plaintiff was, in fact, prescribed Motion on that day. See id. Defendants’ other citations are proper for similar reasons. Accordingly, the Court will not sustain an objection to the Defendants’ facts on this basis. also complained to Dr. Naqvi about his shoulder pain. Pl.’s 56(a), at 4 ¶¶ 18–20.4 On that same day, Dr. Naqvi prescribed Plaintiff Elavil—otherwise known as amitriptyline—which is an antidepressant and can be used to treat anxiety, depression, tension, and can help patients sleep better. Defs.’ 56(a) ¶ 21. Elavil can also be used to treat

neuropathic pain, which is pain coming from damaged nerves, and Dr. Naqvi prescribed this medication to attempt to further address Plaintiff’s complaints of pain. Id. ¶ 22. According to Plaintiff, however, Plaintiff repeatedly informed Dr. Naqvi that the Elavil did not reduce Plaintiff’s pain—it only made Plaintiff sleepy. Pl.’s 56(a), at 5 ¶ 22. Dr. Naqvi wrote the Elavil prescription for three months and instructed Plaintiff to take one twenty-five milligram pill before bedtime. Defs.’ 56(a) ¶ 23. According to Defendants, Plaintiff received Elavil daily from August 27, 2017 until April 17, 2018, id. ¶ 24, though according to Plaintiff, he stopped taking the medication because it “was not working,” Pl.’s 56(a), at 5 ¶ 24. Dr. Naqvi next saw Plaintiff on November 19, 2017 and treated his complaints of pain on the left side of his chest, in his neck, and right shoulder. Defs.’ 56(a) ¶ 25.5 Dr. Naqvi knew

that Plaintiff had a prescription for Motrin at the time, but he renewed Plaintiff’s prescription for Elavil in order to attempt to relieve Plaintiff’s complaints of pain. Id. ¶ 26. Dr. Naqvi again wrote the Elavil prescription for three months and instructed Plaintiff to take one twenty-five milligram pill of Elavil before bedtime. Id. ¶ 27. Prior this prescription’s expiration, a nurse practitioner increased the dosage to fifty milligrams and extended it until May 2018. Id. ¶ 28.

4 Despite Plaintiff’s claim that he complained to Dr.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Katz v. United States
389 U.S. 347 (Supreme Court, 1967)
Estelle v. Gamble
429 U.S. 97 (Supreme Court, 1976)
Bell v. Wolfish
441 U.S. 520 (Supreme Court, 1979)
Hudson v. Palmer
468 U.S. 517 (Supreme Court, 1984)
Anderson v. Liberty Lobby, Inc.
477 U.S. 242 (Supreme Court, 1986)
Wilson v. Seiter
501 U.S. 294 (Supreme Court, 1991)
Pearson v. Callahan
555 U.S. 223 (Supreme Court, 2009)
Chavis v. Chappius
618 F.3d 162 (Second Circuit, 2010)
Todaro v. Ward
565 F.2d 48 (Second Circuit, 1977)
Hill v. Curcione
657 F.3d 116 (Second Circuit, 2011)
Hilton v. Wright
673 F.3d 120 (Second Circuit, 2012)
Colon v. Coughlin
58 F.3d 865 (Second Circuit, 1995)
Beate Bernheim v. Jeffrey Litt
79 F.3d 318 (Second Circuit, 1996)
Graham v. Henderson
89 F.3d 75 (Second Circuit, 1996)
Chance v. Armstrong
143 F.3d 698 (Second Circuit, 1998)

Cite This Page — Counsel Stack

Bluebook (online)
Johnson v. Maurer, Counsel Stack Legal Research, https://law.counselstack.com/opinion/johnson-v-maurer-ctd-2021.